How Oral GLP-1s Work: Sublingual Absorption, SNAC Technology, and Why Format Matters
GLP-1 receptor agonists like semaglutide are peptides — chains of amino acids that your stomach acid would normally destroy before they could do anything useful. Getting them into your bloodstream without a needle requires some clever biochemistry. Here's how each oral format solves that problem.
The Core Challenge: Peptides vs Stomach Acid
Semaglutide is a 31-amino-acid peptide. Drop it into stomach acid and digestive enzymes, and it breaks apart in minutes. That's why injectable GLP-1s bypass the gut entirely — the needle delivers medication straight into subcutaneous tissue where it absorbs into the bloodstream intact.
Oral delivery has to solve this degradation problem. Different formats use different strategies.
SNAC Technology (FDA-Approved Oral Wegovy / Rybelsus)
Novo Nordisk's solution is SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) — a proprietary absorption enhancer that's co-formulated with semaglutide in each tablet. SNAC creates a localized pH buffer in the stomach, temporarily protecting the semaglutide peptide from acid degradation. It also enhances absorption through the stomach lining by transiently opening tight junctions between epithelial cells.
The result: roughly 1% of the oral semaglutide dose reaches systemic circulation. That sounds low, but the tablet is dosed to compensate — oral Wegovy contains much more semaglutide per dose than the injectable version, with the math designed to deliver equivalent therapeutic blood levels.
The tradeoff is the fasting requirement: SNAC works best in an empty stomach with minimal water. Food, coffee, or other medications interfere with the absorption process.
Small Molecule GLP-1: Foundayo (Orforglipron)
Eli Lilly took a completely different approach. Instead of trying to protect a peptide from stomach acid, they developed a small molecule (orforglipron) that activates the GLP-1 receptor but isn't a peptide at all. Small molecules survive stomach acid naturally — that's how most oral medications work.
This is why Foundayo has no food or water restrictions. The molecule doesn't need SNAC protection or an empty stomach. It absorbs through standard GI pathways like any other pill.
Sublingual Delivery (Compounded Drops and Tablets)
Sublingual (under-the-tongue) delivery bypasses the stomach entirely. The medication absorbs through the thin mucous membranes under the tongue directly into capillaries, entering the bloodstream without passing through the digestive tract.
Providers using this approach: SHED and Direct Meds (sublingual drops), plus various dissolvable tablet formats that dissolve under or on the tongue.
The theoretical advantage is clear: no stomach acid contact means no peptide degradation. The practical question is how much actually absorbs. Sublingual bioavailability for large peptides is generally lower than for small molecules, and there's limited published data specifically on sublingual semaglutide absorption rates.
Buccal Delivery (Between Gum and Cheek)
Similar to sublingual but using the buccal mucosa (inner cheek). The cheek lining has a larger surface area than the sublingual region, which may improve absorption for larger molecules. SkinnyRx uses this approach for their oral tirzepatide buccal tablets.
GI Tract Absorption (Capsules and Gummies)
Oral capsules (Zealthy) and gummies (Eden Health) are swallowed and absorbed through the gastrointestinal tract — the same pathway that presents the stomach acid challenge. Without SNAC technology, these formats rely on the compounding pharmacy's formulation to protect the peptide during transit.
The specifics of these formulations aren't publicly disclosed by most compounding pharmacies, which makes it difficult to evaluate their absorption profiles. This is the format category where the gap between FDA-approved and compounded products is largest.
The Honest Answer on Format Effectiveness
FDA-approved oral semaglutide (SNAC technology) and orforglipron (small molecule) have the strongest absorption data — they've been validated in large clinical trials with measured blood levels and weight-loss outcomes. Compounded sublingual and buccal formats have theoretical absorption advantages over swallowed capsules/gummies but lack equivalent clinical validation. Patients should discuss absorption considerations with their prescribing provider.